Jointown Pharmaceutical Group Co., Ltd (600998.SS)
CNY 5.41
(-0.18%)
CNY 5.41
(-0.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.96 Billion CNY | -9.1% |
| 2022 | 4.35 Billion CNY | 21.33% |
| 2021 | 3.59 Billion CNY | -17.46% |
| 2020 | 4.35 Billion CNY | 20.05% |
| 2019 | 3.62 Billion CNY | 98.12% |
| 2018 | 1.82 Billion CNY | -5.75% |
| 2017 | 1.94 Billion CNY | 85.06% |
| 2016 | 1.04 Billion CNY | 22.0% |
| 2015 | 859.97 Million CNY | 34.05% |
| 2014 | 641.54 Million CNY | 24.98% |
| 2013 | 513.3 Million CNY | 4.16% |
| 2012 | 492.81 Million CNY | 40.81% |
| 2011 | 349.99 Million CNY | -20.32% |
| 2010 | 439.25 Million CNY | 22.67% |
| 2009 | 358.08 Million CNY | 40.59% |
| 2008 | 254.7 Million CNY | 29.19% |
| 2007 | 197.14 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.24 Billion CNY | 38.95% |
| 2024 Q3 | 630.86 Million CNY | -49.33% |
| 2024 Q1 | 895.94 Million CNY | 12.4% |
| 2023 Q1 | 729.91 Million CNY | 62.17% |
| 2023 Q3 | 557.52 Million CNY | -50.25% |
| 2023 FY | 3.96 Billion CNY | -9.1% |
| 2023 Q4 | 797.08 Million CNY | 42.97% |
| 2023 Q2 | 1.12 Billion CNY | 53.54% |
| 2022 Q3 | 682.66 Million CNY | -40.22% |
| 2022 FY | 4.35 Billion CNY | 21.33% |
| 2022 Q4 | 450.08 Million CNY | -34.07% |
| 2022 Q1 | 828.05 Million CNY | 1443.78% |
| 2022 Q2 | 1.14 Billion CNY | 37.91% |
| 2021 Q3 | 393.29 Million CNY | -81.45% |
| 2021 Q4 | 53.63 Million CNY | -86.36% |
| 2021 FY | 3.59 Billion CNY | -17.46% |
| 2021 Q1 | 1.02 Billion CNY | -8.42% |
| 2021 Q2 | 2.12 Billion CNY | 106.9% |
| 2020 Q3 | 1.3 Billion CNY | 13.57% |
| 2020 Q2 | 1.14 Billion CNY | 46.23% |
| 2020 Q1 | 784.14 Million CNY | -20.36% |
| 2020 Q4 | 1.11 Billion CNY | -14.06% |
| 2020 FY | 4.35 Billion CNY | 20.05% |
| 2019 Q1 | 387.49 Million CNY | -52.15% |
| 2019 Q2 | 589.31 Million CNY | 52.08% |
| 2019 FY | 3.62 Billion CNY | 98.12% |
| 2019 Q3 | 340.02 Million CNY | -42.3% |
| 2019 Q4 | 984.58 Million CNY | 189.57% |
| 2018 Q2 | 421.67 Million CNY | 41.23% |
| 2018 FY | 1.82 Billion CNY | -5.75% |
| 2018 Q4 | 809.75 Million CNY | 169.95% |
| 2018 Q1 | 298.56 Million CNY | -74.33% |
| 2018 Q3 | 299.96 Million CNY | -28.86% |
| 2017 Q2 | 356.04 Million CNY | 64.51% |
| 2017 FY | 1.94 Billion CNY | 85.06% |
| 2017 Q4 | 1.16 Billion CNY | 464.04% |
| 2017 Q3 | 206.17 Million CNY | -42.09% |
| 2017 Q1 | 216.42 Million CNY | -57.63% |
| 2016 Q4 | 510.83 Million CNY | 267.21% |
| 2016 FY | 1.04 Billion CNY | 22.0% |
| 2016 Q1 | 171.7 Million CNY | -56.02% |
| 2016 Q2 | 227.51 Million CNY | 32.51% |
| 2016 Q3 | 139.11 Million CNY | -38.86% |
| 2015 FY | 859.97 Million CNY | 34.05% |
| 2015 Q4 | 390.37 Million CNY | 209.98% |
| 2015 Q3 | 125.93 Million CNY | -35.78% |
| 2015 Q2 | 196.1 Million CNY | 32.89% |
| 2015 Q1 | 147.56 Million CNY | -53.23% |
| 2014 Q3 | 95.8 Million CNY | -24.36% |
| 2014 Q2 | 126.66 Million CNY | 22.32% |
| 2014 Q1 | 103.54 Million CNY | -61.32% |
| 2014 FY | 641.54 Million CNY | 24.98% |
| 2014 Q4 | 315.52 Million CNY | 229.33% |
| 2013 FY | 513.3 Million CNY | 4.16% |
| 2013 Q1 | 84.85 Million CNY | -69.06% |
| 2013 Q4 | 267.72 Million CNY | 312.2% |
| 2013 Q2 | 95.77 Million CNY | 12.87% |
| 2013 Q3 | 64.95 Million CNY | -32.19% |
| 2012 FY | 492.81 Million CNY | 40.81% |
| 2012 Q4 | 274.26 Million CNY | 601.33% |
| 2012 Q3 | 39.1 Million CNY | -51.54% |
| 2012 Q1 | 98.73 Million CNY | -30.18% |
| 2012 Q2 | 80.7 Million CNY | -18.27% |
| 2011 Q1 | 88.54 Million CNY | -62.84% |
| 2011 Q3 | 42.65 Million CNY | -44.87% |
| 2011 FY | 349.99 Million CNY | -20.32% |
| 2011 Q2 | 77.36 Million CNY | -12.63% |
| 2011 Q4 | 141.41 Million CNY | 231.55% |
| 2010 Q1 | 77.45 Million CNY | 0.0% |
| 2010 Q3 | 47.44 Million CNY | -35.67% |
| 2010 Q4 | 238.27 Million CNY | 402.22% |
| 2010 FY | 439.25 Million CNY | 22.67% |
| 2010 Q2 | 73.74 Million CNY | -4.79% |
| 2009 FY | 358.08 Million CNY | 40.59% |
| 2008 FY | 254.7 Million CNY | 29.19% |
| 2007 FY | 197.14 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 98.95 Million CNY | -3904.257% |
| LBX Pharmacy Chain Joint Stock Company | 1.39 Billion CNY | -183.406% |
| Yifeng Pharmacy Chain Co., Ltd. | 2.05 Billion CNY | -92.837% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 639.62 Million CNY | -519.49% |